Psoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy
A Karamanakos, T Vergou, S Panopoulos… - European Journal of …, 2021 - Springer
New onset or exacerbation of pre-existing psoriasis after therapeutic TNF-α inhibition is a
well-described phenomenon. Over the last two decades, similar cases of paradoxical …
well-described phenomenon. Over the last two decades, similar cases of paradoxical …
[HTML][HTML] Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept)
R Cecchi, L Bartoli - Dermatology Online Journal, 2006 - escholarship.org
The treatment of severe psoriasis in patients with concomitant hepatitis-C virus infection is
quite difficult because several systemic anti-psoriatic drugs are contraindicated owing to …
quite difficult because several systemic anti-psoriatic drugs are contraindicated owing to …
Liver fibrosis is associated with cutaneous inflammation in the imiquimod‐induced murine model of psoriasiform dermatitis
P Vasseur, M Pohin, JF Jégou, L Favot… - British Journal of …, 2018 - academic.oup.com
Background Psoriasis exhibits several extracutaneous manifestations. Little is known about
hepatic parameters specifically associated with psoriasis. Objectives To study whether …
hepatic parameters specifically associated with psoriasis. Objectives To study whether …
Managing psoriasis in patients with HBV or HCV infection: practical considerations
S Piaserico, F Messina, FP Russo - American Journal of Clinical …, 2019 - Springer
Considered more efficacious and safer than traditional systemic drugs, biologic therapies
have dramatically improved the quality of life of patients with psoriasis. Recently, there has …
have dramatically improved the quality of life of patients with psoriasis. Recently, there has …
The enigmatic development of psoriasis and psoriasiform lesions during anti-TNF therapy: a review
B Grinblat, M Scheinberg - Seminars in arthritis and rheumatism, 2008 - Elsevier
OBJECTIVES: The paradoxical observation that antitumor necrosis factor (anti-TNF) agents
are capable of inducing psoriasis and psoriasiform skin lesions while also being therapy for …
are capable of inducing psoriasis and psoriasiform skin lesions while also being therapy for …
Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature
S Piaserico, P Dapavo, A Conti… - Journal of the …, 2017 - Wiley Online Library
Background Little data are available about the safety of TNF‐α inhibitors in patients with
HCV and HBV infection. In particular, data concerning the use of adalimumab in patients …
HCV and HBV infection. In particular, data concerning the use of adalimumab in patients …
Psoriasis induced by anti-tumor necrosis factor alpha agents: a comprehensive review of the literature
F Ciccarelli, M De Martinis, MM Sirufo… - Acta …, 2016 - hrcak.srce.hr
Sažetak Tumor necrosis factor alpha inhibitors revolutionized the management of patients
affected by autoimmune diseases such as inflammatory bowel diseases, rheumatoid …
affected by autoimmune diseases such as inflammatory bowel diseases, rheumatoid …
Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study
HY Chiu, YM Chiu, NFC Liao, CC Chi, TF Tsai… - Journal of the American …, 2021 - Elsevier
Background The increasing use of biologics is accompanied by a risk of hepatitis B (HBV)
and C virus (HCV) reactivation. Objective To determine the predictors of HBV and HCV …
and C virus (HCV) reactivation. Objective To determine the predictors of HBV and HCV …
Drug‐induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis
LJ Dang, JS Lubel, S Gunatheesan… - Australasian Journal …, 2014 - Wiley Online Library
We describe a case of previously unreported autoimmune hepatitis and lupus‐like
syndrome induced by infliximab treatment for chronic plaque psoriasis. The condition …
syndrome induced by infliximab treatment for chronic plaque psoriasis. The condition …
[HTML][HTML] Safety and efficacy of anti-tumor necrosis factors α in patients with psoriasis and chronic hepatitis C
M Salvi, L Macaluso, C Luci, C Mattozzi… - World Journal of …, 2016 - ncbi.nlm.nih.gov
Up to date, in literature, it is still debated the role of anti-tumor necrosis factors (TNF)-α
treatments in hepatitis C virus (HCV) patients. TNF-α performs a lot of functions, it is an …
treatments in hepatitis C virus (HCV) patients. TNF-α performs a lot of functions, it is an …